#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fontan procedure Glomerulonephritis rapidly progressive Nephroblastoma Meningitis meningococcal Encephalopathy neonatal Cardiac arrest Thalassaemia alpha Chemical burn Adenomatous polyposis coli Gaucher's disease type I Macular telangiectasia Von Hippel-Lindau disease Mixed-type liposarcoma Turner's syndrome Leiomyosarcoma More trials…

    Learn about Rare Diseases

    Waldenstrom’s macroglobulinaemia – Trials in Disease Cerebral arteriovenous malformation haemorrhagic – Basic Information Atypical haemolytic uraemic syndrome – Trials in Disease VEXAS syndrome – Trials in Disease Systemic sclerosis pulmonary Indolent systemic mastocytosis – Basic Information Combined immunodeficiency – Treatment Ehlers-Danlos syndrome – Life with Disease Atypical teratoid/rhabdoid tumour of CNS Usher’s syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ZOLPIDEM TARTRATE Metoprolol Succinate PUCOTENLIMAB Necvax-Neo1 4-Hydroxy-N-Desmethyltamoxifen Mk-0616 Telisotuzumab Vedotin GS-248 Quizartinib Dihydrochloride Teriparatide Rifapentine TRV045 Anifrolumab MAPLIRPACEPT Cobicistat Abc-35B-116 Tolu Balsam Vesleteplirsen Tolinapant Lactate Anselamimab More therapies…

    Learn about Your Condition

    Cardiac valve disease Testicular leiomyosarcoma Rosai-Dorfman syndrome Vulvovaginal candidiasis Peyronie's disease Hepatic angiosarcoma Mitochondrial myopathy Biliary adenoma Rhabdomyosarcoma Endocarditis enterococcal Behcet's syndrome Takayasu's arteritis Herpes simplex reactivation Circulatory collapse Triple positive breast cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Triple negative breast cancer

  • Study on the Effectiveness and Safety of Datopotamab Deruxtecan Compared to Chemotherapy in Adults with Advanced Triple-negative Breast Cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Eribulin Mesylate
    • Capecitabine
    • Carboplatin
    Belgium France Germany Hungary Italy Poland +1

  • Study of BT-001 and Pembrolizumab for Patients with Advanced Solid Tumors, Including Sarcoma, Merkel Cell Carcinoma, Melanoma, Breast, and Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Malignant melanoma
    • Neuroendocrine carcinoma of the skin
    • Soft tissue sarcoma
    Investigated Drugs:
    • Bt-001
    • Human Vaccinia Immunoglobulin
    • Pembrolizumab
    Belgium France

  • Study on Avelumab for Patients with High-Risk Triple Negative Breast Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Triple negative breast cancer
    Investigated Drugs:
    • Avelumab
    Italy

  • Study on Nivolumab with Paclitaxel and Carboplatin for Early Stage Triple Negative Breast Cancer Patients

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Triple negative breast cancer
    Investigated Drugs:
    • Nivolumab
    Italy

  • Study on Reduced Dose Intensity of Pembrolizumab and Drug Combination for Patients with Advanced or Metastatic Cancer Responding to Standard Immunotherapy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Lung neoplasm malignant
    • Malignant melanoma
    • Oesophageal squamous cell carcinoma
    Investigated Drugs:
    • Avelumab
    • Dostarlimab
    • Atezolizumab
    France

  • Study on Niraparib for Patients with HER2-Negative BRCA-Mutated or Triple-Negative Breast Cancer with Molecular Disease Detected by ctDNA

    Not recruiting

    3 1
    Investigated Diseases:
    • Triple negative breast cancer
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • Niraparib Tosilate Monohydrate
    Italy The Netherlands Poland Spain
Previous Page
1 … 5 6 7 8 9 … 12
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!